238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.53%
Negative revenue growth while PINS stands at 16.75%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
0.41%
Gross profit growth under 50% of PINS's 21.27%. Michael Burry would be concerned about a severe competitive disadvantage.
4.92%
Positive EBIT growth while PINS is negative. John Neff might see a substantial edge in operational management.
4.92%
Operating income growth under 50% of PINS's 87.79%. Michael Burry would be concerned about deeper cost or sales issues.
2.25%
Net income growth under 50% of PINS's 334.38%. Michael Burry would suspect the firm is falling well behind a key competitor.
4.00%
EPS growth under 50% of PINS's 334.09%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
No Data
No Data available this quarter, please select a different quarter.
0.44%
Share count expansion well above PINS's 0.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.47%
Diluted share count expanding well above PINS's 0.07%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-16.17%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-31.41%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
2318.93%
10Y revenue/share CAGR above 1.5x PINS's 310.48%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
162.39%
5Y revenue/share CAGR at 50-75% of PINS's 217.57%. Martin Whitman would worry about a lagging mid-term growth trajectory.
71.93%
3Y revenue/share CAGR above 1.5x PINS's 46.66%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
2057.92%
10Y OCF/share CAGR above 1.5x PINS's 424.98%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
82.98%
Below 50% of PINS's 592.95%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
32.35%
3Y OCF/share CAGR under 50% of PINS's 69.25%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
5415.81%
Net income/share CAGR above 1.5x PINS's 166.88% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
127.41%
5Y net income/share CAGR similar to PINS's 133.35%. Walter Schloss might see both on parallel mid-term trajectories.
83.56%
Below 50% of PINS's 188.03%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
12534.36%
Equity/share CAGR of 12534.36% while PINS is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
188.03%
5Y equity/share CAGR above 1.5x PINS's 118.78%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
79.49%
3Y equity/share CAGR above 1.5x PINS's 50.13%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.88%
Firm’s AR is declining while PINS shows 7.06%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-20.89%
Inventory is declining while PINS stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
5.05%
Asset growth above 1.5x PINS's 2.28%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.59%
BV/share growth above 1.5x PINS's 2.58%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
19.03%
We have some new debt while PINS reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
0.71%
R&D dropping or stable vs. PINS's 8.43%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-4.99%
We cut SG&A while PINS invests at 22.36%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.